Influence of solvents on the crystal habit and properties of rofecoxib and celecoxib: No evidence of polymorphism

被引:4
|
作者
Raval, M. K. [1 ]
Babu, P. R. Sathesh [2 ]
Thimmasetty, J. [3 ]
Parikh, R. K. [4 ]
Sheth, N. R. [1 ]
Subrahmanyam, C. V. S. [2 ]
机构
[1] Saurashtra Univ, Dept Pharmaceut Sci, Rajkot 360005, Gujarat, India
[2] Gokaraju Rangaraju Coll Pharm, Hyderabad, Andhra Pradesh, India
[3] Bapuji Pharm Coll, Davanagere, Karnataka, India
[4] LM Coll Pharm, Ahmadabad, Gujarat, India
关键词
Celecoxib; crystallization; polymorphism; rofecoxib;
D O I
10.4103/0976-9234.75704
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: In many cases, drugs can exist in more than one crystalline form; the phenomenon is known as "polymorphism." Though the polymorphs are chemically identical, they exhibit different physicochemical properties, viz., melting point, solubility, X-ray diffraction pattern, etc., which further affect the biological properties of drugs. The purpose of this work was to study the effect of solvents on crystallization, solubility and dissolution of rofecoxib and celecoxib. Materials and Methods: The crystals were prepared by using different solvents. The melting point, solubility, dissolution, Fourier-transformed infrared (FT-IR), X-ray diffraction (XRD), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM) studies were carried out to confirm the polymorphism in drugs. Result: The results indicate that the crystals obtained from different solvents exhibited different physicochemical properties. Though FT-IR and XRD gave an indication of different crystal morphs, DSC proved absence of any polymorphic behavior in the crystals of rofecoxib and celecoxib. Conclusion: Crystals having the desired physicochemical properties may be obtained by selecting solvents of specific polarities.
引用
收藏
页码:40 / 50
页数:11
相关论文
共 50 条
  • [1] Impact of Crystal Habit on Biopharmaceutical Performance of Celecoxib
    Modi, Sameer R.
    Dantuluri, Ajar K. R.
    Puri, Vibha
    Pawar, Yogesh B.
    Nandekar, Prajwal
    Sangamwar, Abhay T.
    Perumalla, Sathyanarayana R.
    Sun, Changquan Calvin
    Bansal, Arvind K.
    CRYSTAL GROWTH & DESIGN, 2013, 13 (07) : 2824 - 2832
  • [2] Modification of the crystal habit of celecoxib for improved processability
    Banga, Sheere
    Chawla, Garima
    Varandani, Deepak
    Mehta, B. R.
    Bansal, Arvind K.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (01) : 29 - 39
  • [3] On the influence of companion solvents on the crystallisation speed and crystal habit of potassium suflate
    Wenk, W
    ZEITSCHRIFT FUR KRYSTALLOGRAPHIE UND MINERALOGIE, 1909, 47 (02): : 124 - 162
  • [4] Polymorphism, crystal structure and crystal habit of β-artemether
    Zhang Y.
    Liu Q.
    Zhang D.
    Jiang Y.
    Huagong Xuebao/CIESC Journal, 2011, 62 (10): : 2958 - 2963
  • [5] ASPIRIN DISSOLUTION - POLYMORPHISM, CRYSTAL HABIT OR CRYSTAL DEFECTS
    MITCHELL, AG
    MILAIRE, BL
    SAVILLE, DJ
    GRIFFITHS, RV
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 (07) : 534 - +
  • [6] THE EFFECT OF SOLVENTS AND CRYSTALLIZATION CONDITIONS ON CRYSTAL HABIT OF CHOLESTEROL
    GARTI, N
    KARPUJ, L
    SARIG, S
    CRYSTAL RESEARCH AND TECHNOLOGY, 1981, 16 (10) : 1111 - 1115
  • [7] Effect of Crystal Habit on Intrinsic Dissolution Behavior of Celecoxib Due to Differential Wettability
    Modi, Sameer R.
    Dantuluri, Ajay K. R.
    Perumalla, Sathyanarayana R.
    Sun, Changquan Calvin
    Bansal, Arvind K.
    CRYSTAL GROWTH & DESIGN, 2014, 14 (10) : 5283 - 5292
  • [8] Role of Solvents in Improvement of Dissolution Rate of Drugs: Crystal Habit and Crystal Agglomeration
    Maghsoodi, Maryam
    ADVANCED PHARMACEUTICAL BULLETIN, 2015, 5 (01) : 13 - 18
  • [9] The influence of additives on the crystal habit of gibbsite
    Seyssiecq, I
    Veesler, S
    Pèpe, G
    Boistelle, R
    JOURNAL OF CRYSTAL GROWTH, 1999, 196 (01) : 174 - 180
  • [10] INFLUENCE OF THE CRYSTAL HABIT ON STATIC ELECTRICITY AND FLOW PROPERTIES OF ACETYLSALICYLIC-ACID
    MPENZA, EB
    GILLARD, J
    ROLAND, M
    JOURNAL DE PHARMACIE DE BELGIQUE, 1981, 36 (04) : 231 - 236